Nisa Investment Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.6K Buy
2,100
+369
+21% +$5.89K ﹤0.01% 1988
2026
Q1
$25.7K Buy
1,731
+5
+0.3% +$73 ﹤0.01% 1918
2025
Q4
$27.5K Sell
1,726
-498
-22% -$7.06K ﹤0.01% 1819
2025
Q3
$24.6K Hold
2,224
﹤0.01% 1907
2025
Q2
$18.8K Hold
2,224
﹤0.01% 1971
2025
Q1
$17.9K Sell
2,224
-111
-5% -$899 ﹤0.01% 1928
2024
Q4
$21K Buy
2,335
+70
+3% +$571 ﹤0.01% 1924
2024
Q3
$16.6K Buy
2,265
+319
+16% +$1.98K ﹤0.01% 1965
2024
Q2
$11.1K Buy
1,946
+730
+60% +$3.85K ﹤0.01% 2116
2024
Q1
$6.09K Buy
1,216
+80
+7% +$543 ﹤0.01% 2100
2023
Q4
$10.2K Sell
1,136
-4,130
-78% -$34K ﹤0.01% 2040
2023
Q3
$40.9K Hold
5,266
﹤0.01% 1784
2023
Q2
$51K Buy
5,266
+1,000
+23% +$10.4K ﹤0.01% 1743
2023
Q1
$47K Buy
4,266
+4,130
+3,037% +$36.4K ﹤0.01% 1731
2022
Q4
$1K Buy
136
+27
+25% +$157 ﹤0.01% 2393
2022
Q3
$1K Sell
109
-3,291
-97% -$28.5K ﹤0.01% 2389
2022
Q2
$34K Buy
+3,400
New +$38K ﹤0.01% 1866

Other funds holding AUPH

Nisa Investment Advisors's AUPH Position: Q2 2026 in Review

Nisa Investment Advisors increased its Aurinia Pharmaceuticals (AUPH) stake by 21% in Q2 2026, buying an estimated $5.89K and bringing the position to 2,100 shares worth $35.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1988.

Nisa Investment Advisors first reported a position in AUPH in Q2 2022 and has held it in 17 quarters since. The position peaked at $51K in Q2 2023. 124 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Nisa Investment Advisors held 2,100 shares of Aurinia Pharmaceuticals worth $35.6K as of Q2 2026.
  • Nisa Investment Advisors bought 369 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $5.89K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1988 holding.
  • Nisa Investment Advisors first reported a position in Aurinia Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • Nisa Investment Advisors's Aurinia Pharmaceuticals position peaked at $51K in Q2 2023.
  • 124 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.